Chodankar RR

No ORCID on file · 5 papers in corpus · active 2020-2023

Study types

  • review 2
  • article 1
  • other 1

Condition tags

  • adenomyosis 1
other 2023
EClinicalMedicine ·doi:10.1016/j.eclinm.2023.101995

BACKGROUND: Heavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids. We compared the effectiveness of ulipristal acetate …

2022
Frontiers in reproductive health ·doi:10.3389/frph.2022.820029

Abnormal uterine bleeding (AUB) in the reproductive years in non-pregnant women comprises a group of symptoms that include abnormal frequency and the irregular onset of flow as well as prolonged and heavy menstrual bleeding. It is a common,…

review 2022
Nature reviews. Endocrinology ·doi:10.1038/s41574-021-00629-4

Menstruation is a physiological process that is typically uncomplicated. However, up to one third of women globally will be affected by abnormal uterine bleeding (AUB) at some point in their reproductive years. Menstruation (that is, endome…

article 2021
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.02.008

ObjectiveTo study the impact of the progesterone receptor modulator (PRM), ulipristal acetate (UPA), on endometrial morphology and function.DesignCross-sectional.SettingUniversity Research Institute.Patient(s)Endometrial biopsies from 16 pa…

review 2020
Journal of molecular endocrinology ·doi:10.1530/jme-19-0238

Abnormal uterine bleeding (AUB) is a chronic, debilitating and common condition affecting one in four women of reproductive age. Current treatments (conservative, medical and surgical) may be unsuitable, poorly tolerated or may result in lo…